Autopsy report · NCT03714555
Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine
Cause of deathSlow enrollment
“Study was closed due to low subject enrollment at site.”
Life of this trial
- Registered 1 year before it started.
- Ran for about 9 months before it stopped.
- 1 participant enrolled.
- Results were posted on the registry 3 years 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- HonorHealth Research Institute
- Sponsor type
- University, hospital or other
- Conditions
- Metastatic Pancreatic Cancer
- Interventions
- Safety Laboratories; AE Assessment; Physical Exam; Concomitant Medication Review; Tumor Imaging; nab-paclitaxel (Abraxane)/gemcitabine (Gemzar) Protocol Plus Disulfiram/Copper Gluconate
- Participants
- 1
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Dexamethasone to Treat Acute Chest Syndrome in People With Sickle Cell Disease
“Study was closed June 23, 2008 due to low enrollment.” - Salvage Cryotherapy in Recurrent Prostate Cancer
“Study was ended due to low enrollment” - Prospective Study of Non-operative Management of SBO Without Nasogastric Tube Placement
“Study was closed due to lack of personnel for recruitment/enrollment purposes.” - A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer
“Study closed to enrollment due to low accrual.” - Hand Injected Ventriculography vs. Power Injected Left Ventriculography
“Study was stopped due to low enrollment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.